How much room is there for price reduction in centralized procurement? Great price comparison of generic drugs between China and India!

The third round of national centralized mining is expected to start next year The price of the first two rounds of centralized mining has fallen off a precipice So is there any room for the third round bid price to continue to decline? In fact, compared with the lowest purchase price in 2018 in the alliance region, the average price of the proposed mid-range selection in September this year's "4 + 7" expansion procurement results is 59%; compared with the price level of the "4 + 7" pilot selection, the average price is 25% Now that the price has declined substantially, will the next bidding continue to decline? How much is the real base price? Is there a reference? Last summer's hot film "I am not the God of medicine" tells us that drug dealers smuggled a large number of cheap anti-cancer generic drugs from India Although it challenges the authority and bottom line of the law, hundreds of cancer patients and their families saw the hope of survival India's generic drugs are popular all over the world because of their low price and good quality There is no doubt about their world influence At present, India's generic drugs are sold to dozens of countries in the world, including the United States, Britain, Germany, etc., and the United States is the largest source of Indian generic drugs India has more than 500 FDA certified pharmaceutical factories Data shows that from 2012 to 2016, total exports increased from US $10.1 billion to US $16.9 billion, with a compound annual growth rate of 13.73% In terms of the proportion of export countries, the United States is the main export market of India's overall drugs, accounting for 38% of India's total exports in 2017 and 4.9% of India's total exports in 2016 India's generic drugs are cheap and recognized by the strictest drug regulation in the world, including the United States Then we take the price of generic drugs in India as a reference, and compare the bid price of "4 + 7" expansion and centralized purchase It is estimated that the purchase of the third tire volume, which drugs have room for price reduction, and which price is the lowest price in the market According to the analysis of 24 varieties collected (excluding montmorillonite powder), we can see that except for injection and gefitinib, the unit price of most varieties in India is less than 1 yuan According to the price comparison of generic drugs between China and India, we found that the price of 14 varieties of drugs is still higher than that of generic drugs in India And most of the drugs are much higher than, or even several times as much as, Indian generic drugs There is still 50% to 90% room for price reduction for these drugs The lowest price of flurbiprofen axetil injection is 21.88 (Beijing Taide) However, the price of drugs of the same specification in India is only 2.49, which is still 8.7 times higher than that in India Similarly, the domestic prices of montelukast sodium tablets (the lowest price is 3.79 for Shanghai anbisheng), escitalopram oxalate tablets (the lowest price is 3.98 for Dongting pharmaceutical industry) and olanzapine tablets (the lowest price is 2.48 for Qilu pharmaceutical industry) are 5-7 times higher than those of India In addition, there is also a large price reduction space for levetiracetam tablets, clopidogrel bisulfate tablets, pemetrexed for injection and enalapril maleate tablets On the contrary, the market competition of some drugs has been very full, and the price of centralized purchase is only one tenth of India's price, or even one tenth of India's price For example, the price of entecavir dispersive tablet in India is 7.2, while the price of centralized purchase is only 0.18 (Suzhou Dongrui), only 1 / 40 of the price of India The price of tenofovir dipivoxil fumarate tablets in India is 3.53, and the price of centralized purchase is only 0.29 (Qilu pharmaceutical), which is 1 / 12 of the price of hair in India In addition, the competition of amlodipine besylate tablets (the lowest bid price is 0.06 for Suzhou Dongrui), irbesartan tablets (the lowest bid price is 0.33 for Haizheng pharmaceutical), lisinopril tablets (the lowest bid price is 0.23 for Huahai pharmaceutical) and risperidone tablets (the lowest bid price is 0.05 for Qilu pharmaceutical) is also very full.